Qlife reports first milestone achieved and on track with Chinese collaboration
UPDATE: Qlife has previously reported the potential of its Chinese collaboration and is now updating accordingly: Qlife’s collaboration with Hipro Biotechnology to bring home-hospital blood biomarker testing into the Chinese market and elsewhere – is progressing according to plan and has been further expanded with a focus on additional biomarker tests.The collaboration consists of four major parts: 1. Integration of reagents 2. Regulatory approval in China 3. Distribution and sales in China 4. Production of Egoo in China Integration of reagents The parties have worked